Pharming News
Most Popular Pharming Story
Pharming shares sink after Rhucin gets thumbs down
There's new trouble for Pharming's Rhucin, an experimental treatment for hereditary angioedema. Pharming shares plunged after the company announced that the EMEA's Committee for Medicinal Products Read more...
Latest Headlines
- February 28, 2011
- February 23, 2011
- September 13, 2010
- May 17, 2010
- July 11, 2008
- March 20, 2008
- October 19, 2007
- October 11, 2007
- August 30, 2007
- August 20, 2007
- July 30, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
